Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma.

SLN status did not impact the prognostic strength of this risk score, since after stratifying by SLN status, the gene signature risk score remained highly significant ( p = 0.0002) ( Figure 3 ).

also in 132,142 other papers